Poldine

Poldine is a medicinal substance that is used to treat gastric and duodenal ulcers. Poldine is an atropine analogue that suppresses gastric acid secretion and prevents the development of ulcers.

Poldine is administered orally and its trade name is Nacton. The medicine may have some side effects, including dry mouth, blurred vision, difficulty urinating, and increased heart rate. Therefore, as with any other medicine, it is necessary to monitor the patient's health and consult a doctor if any problems arise.

One of the main benefits of Poldine is its ability to suppress the secretion of gastric juice, which reduces the risk of developing gastric and duodenal ulcers. Additionally, the medicine may help reduce pain and inflammation associated with peptic ulcers.

Poldine and Nacton are the same medicine, so when purchasing at a pharmacy, you can check whether there are analogues of this drug under other trade names.

Although Poldine can be an effective medicine for treating gastric and duodenal ulcers, it must be remembered that it is a drug and should only be prescribed by a doctor. It is also important to follow the directions for use and not exceed the recommended dose.

Poldine is a medicinal substance that is similar in action to atropine. It is used to treat gastric and duodenal ulcers, as well as to suppress the secretion of gastric juice.

When taken orally, Poldin may cause side effects such as dry mouth and eyes, difficulty urinating, and rapid heartbeat. However, these effects are usually short-lived and not serious.

The trade name of Poldin is Nacton, which can be purchased in pharmacies. Before use, you should consult your doctor.

Poldin and his story

Poldine, also known as Poldine, is a medicine used to treat various gastrointestinal conditions, including stomach ulcers and duodenal acid. It contains a semi-derivative of hyoscyamine, an atropine alkaloid that has the ability to suppress gastric acid secretion and reduce inflammation in the gastrointestinal tract.

Poldine was first synthesized in 1948 by an Italian chemist known as Luigi Polin or Pol D'Inne. This substance was developed as part of a study to find new agents to relieve the symptoms of motion sickness and